共 39 条
- [31] Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type IMOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (04)Shi, XiaoxiaBortolussi, GiuliaCollaud, FannyLebrun, Pierre-Romainten Bloemendaal, LysbethGuerchet, Nicolasde Waart, Dirk RudiSellier, PaulineDuijst, SuzanneVeron, PhilippeMingozzi, FedericoKishimoto, Takashi KeiRonzitti, GiuseppeBosma, PiterMuro, Andres F.
- [32] 2 DIFFERENT MISSENSE MUTATIONS AT THE UGT1 GENE-COMPLEX LOCUS THAT GENERATE PH-SENSITIVE ACTIVITY OF THE MAJOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE IN CRIGLER-NAJJAR TYPE-II PATIENTSFASEB JOURNAL, 1995, 9 (06): : A1267 - A1267RUBALTELLI, DCIOTTI, MRUBALTELLI, FFOWENS, IS
- [33] Crigler-Najjar syndrome type II in a Chinese boy resulting from three mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene and a family genetic analysisBMC Pediatrics, 14Bixia ZhengGuorui HuJin YuZhifeng Liu
- [34] Crigler-Najjar syndrome type II in a Chinese boy resulting from three mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene and a family genetic analysisBMC PEDIATRICS, 2014, 14Zheng, BixiaHu, GuoruiYu, JinLiu, Zhifeng
- [35] Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type IIBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1406 (03): : 267 - 273Yamamoto, KSato, HFujiyama, YDoida, YBamba, T
- [36] Development of AAV2/8-Mediated Gene Therapy Clinical Trial for Crigler-Najjar Syndrome Type I: Optimization of Liver-Specific Expression CassetteMOLECULAR THERAPY, 2013, 21 : S192 - S193Pastore, NunziaAuricchio, AlbertoBrunetti-Pierri, Nicola
- [37] Direct Hepatic Injections of HDAd Vector Are More Efficient and Safer Than Systemic Intravenous Injections for Liver-Directed Gene Therapy of Crigler-Najjar Syndrome Type IMOLECULAR THERAPY, 2012, 20 : S57 - S58Pastore, NunziaNusco, EdoardoPiccolo, PasqualeVetrini, FrancescoPalmer, DonnaNg, PhilipBrunetti-Pierri, Nicola
- [38] Direct hepatic injections of HDAd vector are more efficient and safer than systemic intravenous injections for liver-directed gene therapy of Crigler-Najjar syndrome type I.HUMAN GENE THERAPY, 2012, 23 (10) : A78 - A78Pastore, NunziaNusco, EdoardoVetrini, FrancescoPalmer, DonnaNg, PhilipVitek, LiborBrunetti-Pierri, Nicola
- [39] Ultrasound-Guided Hepatic Injections of HDAd Vector Are More Efficient and Safer Than Systemic Intravenous Injections for Liver-Directed Gene Therapy of Crigler-Najjar Syndrome Type IMOLECULAR THERAPY, 2013, 21 : S136 - S136Pastore, NunziaNusco, EdoardoPiccolo, PasqualeCastaldo, SigismondoVetrini, FrancescoPalmer, DonnaVitek, LiborNg, PhilipBrunetti-Pierri, Nicola